Bentham Science Publishers, a major STM journal publisher of 116 titles and more than 240 open access journals, answers the information needs of the pharmaceutical, bio ,medical, engineering and technology research community. Leading journals include Current Molecular Medicine (Impact Factor 5.212) and Current Medicinal Chemistry (Impact Factor 4.63) :


Eureka Science is an innovative and dedicated event management and international publishing specialist based in Sharjah Airport International Free Zone in United Arab Emirates. We offer a unique range of services to our clients varying from individuals to large multinational corporations, strengthened by our core values of quality, efficiency and knowledge in client service. Equipped with a full- fledged Event Management Division, Eureka Science offers a complete solution for the management and marketing of conferences and symposia from lining up resource persons and participants in any discipline of science, social science and humanities etc. to promotional activities and managing funds catering to Development of the Idea, Management of the Full/Partial Event & Following up Post-Event Matters.

Also, Our experience and expertise in Publishing and related ancillary Information Technology fields ideally place us to convert concepts and ideas into reality.

Publishing services include but are not limited to:

• Pre-Publishing (Editing, Proofreading, etc.)

• Desktop Publishing (Composing, Graphics, Printing, Online Publishing, etc.)

• Post-Publishing (Indexing, Distribution etc.)

• E-Publication (Web site Designing, Data Conversion, CD ROM Publishing, etc.)

Founded in 1988 by Federal Decree the Higher Colleges of Technology (HCT) is the largest higher educational institution in the UAE, having a well-respected reputation for innovative learning. Over 19,000 students attend 17 modern men’s and women’s campuses in Abu Dhabi, Al Ain, Dubai, Ras Al Khaimah, Sharjah, Fujairah and Madinat Zayed/Ruwais. HCT offers over 90 different, English-taught programs in Applied Communications, Business, Engineering, Information Technology (IT), Health Sciences and Education at various levels. All programs are designed in consultation with business and industry leaders to ensure the students’ skills are job-relevant and to the highest standards. Students learn in a technologically sophisticated, e-learning environment that encourages development of independent and life-long learning skills. HCT graduates are eagerly sought by employers as they are capable of operating effectively in today’s global business environment. Over 48,000 academic credentials have been awarded to its graduates. The HCT has established dynamic relationships with UAE companies and organizations and the world’s leading universities and organizations.

Dubai Women’s College (DWC) recently celebrated its 20th anniversary in the company of students, faculty, staff, partners, alumnae, and friends. Founded in 1989, DWC began its legacy with only 145 students taking classes in a converted Dubai car showroom. The first batch of brave young ladies lead the way for women in the UAE not only by getting an education, but by making pioneering steps to join the predominantly male workforce after graduating. Today, 22 years later, DWC has a state of the art campus spread over 350,000m2 of cultivated land, with 2,200 students enrolled, and offering Bachelors degrees in five academic programs.

UAE Genetics Diseases Association founded in 2006 under the patronage of His Highness Sheikh Nahyan Bin Mubarak Al- Nahyan, the Former-Minister of Higher Education and Scientific Research, and under the supervision of Dr. Maryam Matar, the founder and Board director of UAEGDA, the aim of our association is to increase awareness programs with the objective of preventing the occurrence of common genetic disorders in the UAE and the region, and to strive to reduce the prevalence and impact of common genetic disorders in the UAE through preventative awareness programs, screening based on research studies and knowledge sharing, conducted by experts in the field using the most innovative technology at the lowest costs.


CinnaGen was founded in 1994 with the goal of manufacturing hi-tech products in biotechnology. Production activities are performed in our 11,000m2 area with over 6,000 m2area clean rooms. We are committed to quality assurance and regulatory affairs and absolute practice of cGMP. The company provides a one-stop shop solution from API to finish product formulation.Biopharmaceutical grade APIs : re-Hu PTH, re-Hu FSH, re-Hu GCSF & PEG-GCSF, re-Hu Growth Hormone, re-Hu Erythropoietin , Buserelin.Finish products: CinnoVex (Interferon Beta-1a, 30µg) , ReciGen (Interferon Beta-1a, 44µg), CinnoPar (Teriparatide),Cinnal-f (Follitropin Alfa) , PegaGen (Peg-filgrastim), CinnaFact (Buserelin Acetate), CinnaPoietin (Epoetin Beta), Reditux (Rituximab).

MEMBS is the only vibrant community devoted to serving the Molecular Biology knowledge and applications in the Middle East and the Arab World.

The principal aim of MEMBS is to bring together all Molecular Biology-related resources from all over the world and present them to the Middle East and Arab world in many forms, in order to:

  1. Improve educational and research competence in the region.

  2. Promote scientific and professional interchange with the rest of the world..

  3. Enhance the scientific capability of our region in this field.

  4. Boost communication between all parties who share these aims.

  5. Increase awareness about MB related disciplines of Science in the region.

  6. Serve humanity.

G.Innovative Biotech is a knowledge-Based leading Biotech Company active in production and distribution of wide range of cell culture media and biotech preparations under INOCLON brand name.

The company develops, manufactures and distributes high quality cell culture media, molecular reagents related to tissue and cell culture applications including basal salt solutions and buffers, sera, special media and flexible packaging systems.

Biopharma companies and academic research center are our valuable customers and we do our best to provide excellent after-sales services to our clients.

G. Innovative Biotech is also ready to produce customer-made formula to meet specific customer’s need. All manufacturing processes are performed under cGMP regulations and Company meet the standard of ISO 13485:2003.

Eureka Conference is an International group providing event management and publishing services for the last many years. We have extensive experience in holding massive, high profile, International scientific conferences that attract the most prominent people in their relevant fields.
In addition to our event management services, we also provide a vast array of publishing services to various international organizations, ranging from composing, copy editing to printing and distribution. Our publication services portfolio extends from purely online publishing to the more traditional hard copy one. Also, we offer a variety of Web related services. Our team of technical and highly qualified professionals aims to provide a reliable and cost-effective solution to all our customers’ publishing related requirements. Our years of experience and expertise in publishing and related ancillary information technology fields, ideally rank us among the best to transform your concepts and ideas into reality.


The Intellectual Property & Science division of Thomson Reuters became the first to offer a complete suite of services designed to assist customers to access the world’s most highly regarded science and technology information so that they can effectively conduct R&D projects. Thomson Reuters helps drive the innovation lifecycle around the world and is part of the process that enables the discovery, development, and delivery of the world’s greatest innovations.

Prestwick Chemical is a drug discovery company that successfully identifies hits for its partner's target and optimizes the hits into clinical candidates. With our premium partners, we have developed the capacity to integrate the whole drug research: Hit identification using smart screening libraries and/or large scale pharmacophore based virtual screening, hit validation, hit to lead expansion, lead optimization and profiling. Our in-house expertise relies on long term experience in medicinal chemistry, with unprecedented success: 6 compounds made by Prestwick are currently in clinical development, from Phase I to Phase III.

Summary of products:

Prestwick performs fully integrated drug research: Hit identification using smart screening libraries and/or large scale pharmacophore based virtual screening, hit validation, hit to lead expansion, lead optimization and profiling.Since October 2011, we can speed-up the iterative cycles of design and synthesis by a close partnership for primary and secondary assays (project/target dependent).

Business Model: Partnering strategy/collaboration

Our partnership/collaboration strategy includes pure FTE based fee for service contract research to objective driven research collaborations ( both with no strings attached), as well as collaborative projects with shared risks and IP.

Client portfolio

Our Medicinal Chemistry clients and project partners include or have included the following pharma companies: Actelion, DSM, GSK, J&J, Merck KG and Merck Serono, NPS Inc., Nycomed, Sanofi ... Other smaller client reference list can be obtained upon request.

Our library clients essentially include all major big pharma companies as well as over 300 smaller pharma or biotech firms and academic labs.

   















 
Conferences & Trade shows [Webmaster]   Copyright © 2019 6th International Conference on Drug Discovery & Therapy